Robert Avery, MD
Robert Avery, MD
California Retina Consultants
Christopher Brittain
Christopher Brittain
Genentech
Netan Choudhry, MD
Netan Choudhry, MD
Vitreous Retina Macula Specialists of Toronto
Emmett T. Cunningham Jr., MD, PhD, MPH
Emmett T. Cunningham Jr., MD, PhD, MPH
Eyconis / HealthQuest Capital Management
Pravin U. Dugel, MD
Pravin Dugel, MD
Ocular Therapeutix
Jay Duker, MD
Jay Duker, MD
Tufts University School of Medicine / EyePoint Pharmaceuticals
Ravi Durvasula, PhD
Ravi Durvasula, PhD
Alcon
Mehdi Gasmi, PhD
Mehdi Gasmi, PhD
Adverum Biotechnologies
Chuck Hess
Chuck Hess
Bausch + Lomb
Michael Keyoung, MD, PhD
Michael Keyoung, MD, PhD
CBC Group/C-Bridge Capital
Ash Khanna, PhD
Ash Khanna, PhD
Pivotal bioVenture Partners
Szilárd Kiss, MD
Szilárd Kiss, MD
Weill Cornell Medicine
Mihir Mantri
Mihir Mantri
Piper Jaffray
Jason Menzo
Jason Menzo
Foundation Fighting Blindness
Darius Moshfeghi, MD
Darius Moshfeghi, MD
Stanford University School of Medicine / Pr3vent
Timothy G. Murray, MD
Timothy G. Murray, MD
Miami Ocular Oncology & Retina (MOOR)
Steve Pakola, MD
Steve Pakola, MD
REGENXBIO
Angelo Rago
Angelo Rago
Carl Zeiss Meditec
Firas Rahhal, MD
Firas Rahhal, MD
ExSight Ventures & Retina Vitreous Associates Medical Group
José Sahel, MD
José Sahel, MD
University of Pittsburgh School of Medicine
Susan Schneider, MD
Susan Schneider, MD
Eloxx Pharmaceuticals
Ron Weiss, MD
Ron Weiss, MD
InFocus Capital Partners / Chicago Eye Consultants
Glenn C. Yiu, MD, PhD
Glenn C. Yiu, MD, PhD
UC Davis Health Department of Ophthalmology & Vision Science